Compounding Pharmacies Explained

What Is Pharmaceutical Compounding?

Pharmaceutical compounding is the practice of creating a customized medication for an individual patient — altering the formulation, strength, dosage form, or flavor of a drug that is not commercially available in the form needed. Compounding pharmacies mix, combine, or alter drug ingredients based on a prescriber's order.

Compounding has a long history in pharmacy practice — before mass drug manufacturing, essentially all medications were compounded individually for each patient. Modern compounding serves patients for whom commercially available products do not meet their specific clinical needs.

Legitimate Uses for Compounded Drugs

Compounding is clinically appropriate when:

• A drug is unavailable commercially: A drug may have been discontinued, be in short supply, or never been manufactured commercially despite a clear clinical need.
• Dosage adjustment is needed: A child or pet requires a fraction of the lowest commercially available dose, or a patient needs a dose between standard manufactured strengths.
• Alternative dosage form is required: A patient cannot swallow tablets and needs a liquid formulation, or cannot use an injection and needs a transdermal (skin-absorbing) cream.
• Allergen or excipientExcipient

  An inactive ingredient in a drug formulation that serves a purpose other than the therapeutic effect — such as binding, filling, flavoring, coloring, or preserving the medication. While pharmacologica

  avoidance: A patient has an allergy to a specific dye, preservative, or inactive ingredientInactive Ingredient

  Any component of a drug product other than the active ingredientActive Ingredient

  The component of a drug product that produces the intended therapeutic effect. The active pharmaceutical ingredient (API) is what the drug does — everything else in the formulation (binders, fillers,

  . Inactive ingredients include binders (hold tablets together), fillers (bulk up the tablet), disintegrants (help tablets break apart),
  in all commercial formulations.
• Flavor modification for pediatric or veterinary use: Medications flavored to improve palatability for children or animals.
• Combination products: A prescriber wants two medications combined in a single preparation for convenience or adherence.

These are legitimate, medically justified reasons to use a compounded product.

How Compounding Is Regulated

Compounding pharmacies occupy a complex regulatory space that differs significantly from commercial drug manufacturing. FDA-approved manufactured drugs undergo rigorous review of safety, efficacyEfficacy

The maximum therapeutic effect a drug can produce, regardless of the dose given. A drug with higher efficacy can achieve a greater maximum response than one with lower efficacy, even if the latter is

, and manufacturing quality. Compounded preparations — because they are customized for individual patients — are not reviewed by the FDA for safety and efficacy and are exempt from standard drug approval requirements.

State boards of pharmacy are the primary regulators of compounding pharmacies for patient-specific compounding. They set standards for facilities, personnel, quality control, and beyond-use dating (the estimated time the compounded product remains stable and sterile).

The FDA regulates compounding pharmacies that engage in what it terms "large-scale" or "essentially commercial" compounding — producing drugs in bulk without valid patient-specific prescriptions, or shipping large volumes across state lines.

The 2012 meningitis outbreak caused by contaminated injectable steroid compounds from the New England Compounding Center (NECC) — which killed 64 patients and sickened hundreds — demonstrated the catastrophic potential when large-scale compounding occurs outside adequate regulatory oversight. Congress responded with the Drug Quality and Security Act of 2013, creating a new category of regulated compounding entities.

503A vs. 503B Pharmacies

The Drug Quality and Security Act established two categories:

503A pharmacies are traditional compounding pharmacies that compound preparations for identified individual patients based on valid prescriptions. They are regulated primarily by state pharmacy boards. No FDA registration is required, but FDA can inspect and act on safety concerns. Most neighborhood compounding pharmacies operate as 503A facilities.

503B outsourcing facilities are a new category that can produce larger quantities of compounded drugs — including for hospital use — without patient-specific prescriptions. In exchange, they must register with the FDA and are subject to FDA inspection and cGMP-like quality standards. 503B facilities provide an FDA-oversight pathway for larger-scale compounding that was previously unregulated.

When a hospital or clinic orders a compounded product in advance rather than for a specific patient, it should come from a 503B facility. When your prescriber sends a patient-specific prescription to a compounding pharmacy for your individual needs, a 503A pharmacy fills it.

Quality and Safety Considerations

Unlike FDA-approved medications, compounded preparations are not subject to the standardized testing, stability studies, or manufacturing controls that guarantee uniformity across vials, capsules, or tubes. Potential quality concerns include:

• PotencyPotency

  The amount of drug needed to produce a given effect. A more potent drug achieves the same effect at a lower dose. Potency is different from efficacy — a drug can be highly potent but have limited maxi

  variability: The compounded preparation may contain more or less active ingredient than intended. A study of compounded thyroid preparations, for example, found significant variability in actual hormone content.
• Sterility failures: For injectable or ophthalmic products, inadequate sterility technique can introduce microorganisms. This was the mechanism of the NECC tragedy.
• Stability uncertainty: Beyond-use dates for compounded preparations are often based on general guidelines rather than product-specific stability testing.
• Ingredient sourcing: Active pharmaceutical ingredients (APIs) used in compounding must come from FDA-registered suppliers, but the FDA's ability to inspect API suppliers for compounding is limited compared to commercial manufacturing.

These concerns do not mean compounded medications are unsafe — most patient-specific compounding is performed responsibly by skilled pharmacists. But they do mean that compounded preparations carry more inherent uncertainty than FDA-approved products, and that choice is justified only when the clinical need is genuine.

Compounding and Drug Shortages

Drug shortages have created a growing demand for compounded preparations. When a commercially manufactured drug becomes unavailable, hospitals and patients may turn to compounding pharmacies to fill the gap. The FDA maintains a drug shortage database and can issue guidance allowing compounding of specific shortage products under defined conditions.

During drug shortages, compounded versions allow patients to continue therapy. The tradeoff is that the compounded version has not been subject to the same manufacturing oversight as the commercial product. Prescribers and patients should weigh this consideration when evaluating shortage-driven compounding.

Questions to Ask Before Using a Compounding Pharmacy

If your prescriber recommends a compounded medication, ask:

1. Why is the compounded version needed? The clinical rationale should be documented — a commercially available FDA-approved alternative should be the default.

2. Is the pharmacy state-licensed and in good standing? Your state board of pharmacy website lists licensed pharmacies and any disciplinary history.

3. Is the pharmacy accredited? Voluntary accreditation from the Pharmacy Compounding Accreditation Board (PCAB) — now part of NABP — indicates the pharmacy has been independently verified to meet quality standards.

4. Is this a sterile product? Sterile compounding (injections, eye drops) requires specialized facilities and equipment. Verify that the pharmacy has sterile compounding capability if you need an injectable or ophthalmic preparation.

5. What is the beyond-use date, and how should I store it? Stability varies by product; proper storage is essential.

6. Has the pharmacy performed potency testing on this preparation? Some high-quality compounding pharmacies perform independent third-party potency testing on their preparations and can provide a certificate of analysis.

When compounding is used appropriately, for a genuine clinical need, at a quality facility, it provides access to medications that would otherwise be unavailable. The key is ensuring the indication is legitimate and the source is verifiably competent.

This guide is for educational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making changes to your medication regimen.